We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

NZ Bans Avandia Over Cardiovascular Concerns

Law360 (February 18, 2011, 1:39 PM EST) -- New Zealand’s health regulator is pulling diabetes drug Avandia from the shelves, saying a safety review found the medication increased patients’ risk of developing cardiovascular problems.

The New Zealand Ministry of Health said Thursday it would suspend Avandia until GlaxoSmithKline, the drug’s manufacturer, could identify a patient population for which the benefits of taking the drug outweighed the risks.

The medicine will be withdrawn from the market April 29, the agency said, adding that the suspension would affect the fewer than 100 people currently taking Avandia...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.